Related Experiment Video

Updated: Oct 5, 2025

Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

5.1K

Juvenile idiopathic arthritis

Alberto Martini1, Daniel J Lovell2, Salvatore Albani3

  • 1Università degli Studi di Genova, Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DiNOGMI), Genova, Italy. albertomartini@gaslini.org.

Nature Reviews. Disease Primers
|January 28, 2022
PubMed

Insights

Juvenile idiopathic arthritis (JIA) is a chronic childhood inflammatory condition. Advances in JIA treatment focus on rapid disease control and improving quality of life for affected children.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Genetics

Background:

  • Juvenile idiopathic arthritis (JIA) is the most prevalent chronic inflammatory rheumatic disease in children, characterized by unknown etiology and lasting over six weeks with onset before age 16.
  • The current International League Against Rheumatism (ILAR) classification, while valuable for research, faces criticism for not differentiating childhood-specific arthritis from adult forms, prompting the development of new evidence-based classifications.
  • Pathogenesis of JIA involves complex autoimmune and autoinflammatory mechanisms, similar to adult arthritis.

Purpose of the Study:

  • To review the current understanding of Juvenile Idiopathic Arthritis (JIA), including its classification, pathogenesis, and therapeutic advancements.
  • To highlight the evolving treatment goals in JIA, emphasizing rapid disease control and enhanced quality of life.

Main Methods:

  • Literature review of JIA classification systems, pathogenesis, and therapeutic strategies.
  • Analysis of recent advancements in drug therapies and clinical trial methodologies for JIA.

Main Results:

  • Significant improvements in therapeutic options for JIA have emerged due to potent new drugs and structured clinical trials.
  • Treatment aims to achieve inactive disease or clinical remission swiftly, minimize adverse effects, and restore a quality of life comparable to healthy peers.

Conclusions:

  • JIA management has advanced significantly, offering better outcomes for affected children.
  • Improving health-related quality of life is increasingly recognized as a critical treatment objective in JIA, acknowledging its profound impact on children and families.

More Related Videos

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue09:18

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

Published on: February 24, 2023

8.7K
Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients09:31

Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients

Published on: October 16, 2016

9.6K

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
756
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.5K
Ankle Joint01:10

Ankle Joint

The ankle is formed by the talocrural joint (crural = leg). It consists of the articulations between the talus bone of the foot and the distal ends of the tibia and fibula of the leg. The superior aspect of the talus bone is square-shaped and has three areas of articulation. The top of the talus articulates with the inferior tibia. This is the portion of the ankle joint that carries the body weight between the leg and foot. The sides of the talus are firmly held in position by the articulations...
2.0K
Development of the Limb Synovial Joints01:07

Development of the Limb Synovial Joints

Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
1.7K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
74
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
33